Aortic valve replacement (AVR) and ascending aorta replacement were the standard approaches for the management of aortic root aneurysm combined with aortic insufficiency (AI).
Introduction
Aortic valve replacement (AVR) and ascending aorta replacement were the standard approaches for the management of aortic root aneurysm combined with aortic insufficiency (AI).
1
AVR with a bioprosthetic valve increases the risk of reoperation, and AVR with a mechanical valve is associated with anticoagulant-related hemorrhage.
2 Later, two aortic valve-
sparing (AVS) approaches (Yacoub and David

3,4
) were developed to preserve native aortic valves to eliminate lifelong anticoagulant therapy. Although excellent results of these two AVS approaches were documented, 5, 6 most centers' adop-consider AVR as first-line treatment. 1, 7 The Florida (FL) Sleeve technique was introduced at Shands Hospital at UF Health (University of Florida, Gainesville, FL) to simplify the procedural complexity and preserve the native aortic valve in patients with AI secondary to aortic root dilation. 8 The FL
Sleeve procedure does not require coronary artery reimplantation, which decreases the risk of surgical bleeding. 8, 9 Moreover, the most recent study comparing biomechanical characteristics of the FL Sleeve and previous AVS techniques found that the FL Sleeve technique is even superior to previous AVS techniques in biomechanical standpoint as it leads to lower aortic valve stress and prevents possible aortic root distortion or harmful aortic wall stresses. 10 Hess et al 8, 9 and Gamba et al 11 have reported encouraging early and midterm outcomes of the FL Sleeve procedure. In contrast to large studies incorporating David and Yacoub techniques, 5, 7, 12 all prior reports about the FL Sleeve procedure have included limited numbers of patients and reported early or midterm outcomes. 8, 9 The long-term survival rate, freedom from reoperation, aortic valve function, and dimensional stability of the left ventricle following the FL Sleeve procedure remain unknown. Thus, to address these gaps of knowledge, we investigated outcomes of all patients who underwent the FL Sleeve procedure at our center.
Materials and Methods
Study Population
In this retrospective and single-center study, all patients with AI secondary to aortic root aneurysms who underwent the FL Sleeve procedure at Shands Hospital at UF Health (The University of Florida College of Medicine, Gainesville, FL) were included. The study was conducted from May 1, 2002 to January 1, 2016 after the Institutional Review Board approval and waiver of informed consent. However, patients who had the FL Sleeve procedure after March 2006 were consented, allowing us to follow up patients' status and clinical information through their primary care provider (PCP) and cardiologists. Our inclusion criteria were patients with normal or slightly abnormal leaflets and Type I AI secondary to aortic root aneurysm. Patients were excluded from the study for any of the following reasons: severely damaged, prolapsed, or nonfunctional aortic valve leaflets that needed AVR and patients with Type 2 AI.
Procedural Technique
Hess et al 8, 9 have described details of the FL Sleeve procedure. Under cardioplegic arrest on cardiopulmonary bypass (CPB), we transected the ascending aorta immediately above the sinotubular junction. Typically, a total of 4 to 6 subannular mattress sutures were located in the same horizontal level up to 3 mm below the lowest point of the midpoint of the leaflets. Three of these mattresses were in the same line with valve commissures and another one was located under the noncoronary cusp (►Fig. 1). Hegar dilators (Jarit Instruments, Hawthorne, NY) or valve sizers were used for annular sizing. The main clinical goal was to ensure adequate leaflet coaptation and valve competence. The subannular sutures were placed through the sleeve graft and secured over a presized Hegar dilator to prevent narrowing of the annulus. With the sleeve graft temporarily seated, locations of the coronary arteries were marked on the graft, and vertical slits were made to create coronary keyholes. The slits were repaired using simple sutures below the coronary arteries after the sleeve graft was appropriately located over the aortic root. To prevent coronary artery impingement, intraoperative attention to the keyholes and intraoperative transesophageal echocardiography monitoring of ventricular function after CPB is imperative. The sleeve graft is secured at the sinotubular junction with a running horizontal mattress (►Fig. 2). To finalize the aortic root reconstruction, we used a smaller graft distal to the sleeve graft to reduce the sinotubular junction and incorporate the aorta and the sleeve graft via a hemostatic running suture (►Fig. 3).
Patient Outcomes
The primary endpoints chosen were the procedural safety, long-term durability, and freedom from reoperation. 
Results
Patients' Demographics
One hundred and seventy-seven patients with mean age of 49.41 AE 15.37 years were included. Sixteen (9.03%) patients underwent the FL Sleeve procedure in an emergent status due to acute Type A aortic dissection and all others had surgery due to chronic dissection or aortic aneurysm. Thirtyseven (20.9%) patients had Marfan syndrome. Mean AE SD aortic diameter was 53.72 AE 7.85 mm (►Table 1). A majority of patients had concomitant cardiac surgery in addition to the FL Sleeve procedure (N ¼ 123, 69.49%) (►Table 2). 
Long-Term Follow-Up
Clinical follow-up including patients' survival status and need for reoperation was completed for all patients. No patient developed aortic dissection during follow-up. Three (1.69%) patients needed reoperation; 1 (0.56%) patient with a bicuspid valve repair had AVR due to severe AI at 8 months, 1 (0.56%) patient had degeneration of distal aorta from a baseline Type A dissection repair and underwent endovascular aneurysm repair and thoracic endovascular aortic repair at 26 months, and then transcatheter AVR at 30 months due to central AI; and another (0.56%) patient with Marfan syndrome required ascending aorta replacement due to a pseudoaneurysm at 112 months. The mean AE SD duration of freedom from reoperation was 136.99 AE 45.56 months. We estimated patients' overall freedom from reoperation as 99% at 1 year and 98% at 2 to 8 years (►Fig. 1). Freedom from any type of aortic dissection was 100% at 1 to 8 years, whereas freedom from AVR was 99% at 1 year and 98% at 2 to 8 years. Patients had survival rate of 98% at 1 year, 97% at 5 years, and 93% at 8 years (►Fig. 4).
To perform subgroup analysis for patients who had both baseline and long-term (5 and 10 years) follow-up echocardiography, the patients with AVR at 8 and 30 months were excluded. At 5 years, 31 patients had follow-up echocardiography. Of these 31 patients, 8 (8/31, 25.80%) patients had moderate AI and 3 (3/31, 9.67%) others had severe AI preoperatively. Only 2 (2/31, 6.45%) patients remained with moderate AI at 5 years, and no patient with severe AI was identified. Freedom from severe AI was 100% and freedom 
Discussion
This retrospective study includes the largest number of patients who underwent the FL Sleeve procedure. In-hospital mortality rate was 1.69%, and 30-day mortality rate remained the same. The outcomes of the study, including patients' survival rate and freedom from reoperation, were excellent. Two initial studies employing the David and Yacoub techniques had higher rates of early mortality compared to the present series, 4.8 and 4.6% versus 1.69%, respectively. 4, 12 In contrast, two recent studies of the David and Yacoub procedures reported improved 30-day mortality rates (1-1.7%).
13,14
A recent report from Emory on the David procedure had a higher operative mortality at 5.7%. The present study is the only study that has investigated long-term outcome of patients after the FL Sleeve procedure. In the previous study by Hess et al, 9 they reported four late deaths. However, the authors were unable to estimate patients' mid-or long-term survival rates. In this series, we found a 97% survival rate at 5 years and 93% survival rate at 8 years. Kvitting et al 19 examined previous AVS techniques and found a similar survival rate at 5 years (98.7%). In the study by the Hannover Medical School group, including 450 patients with the David procedure, 5-year survival was 85% and 10-year survival rate decreased to 70%. 12 David et al 20 reported 36 to 83% survival rate at 8 years' follow-up from David procedures. Coselli et al 14 employed the David procedure and reported a survival rate of 86.9% at 8 years. Importantly, no patients with acute aortic dissection died throughout our study and this cohort had 100% survival rate at 1 to 8 years. In a contrasting report, patients with acute aortic dissection who underwent a Yacoub procedure had 1, 5, and 10 years survival rates of 73, 63, and 53%. 
19
Another study on AVS procedures found 88 and 84% freedom from aortic dissection at 5 and 10 years. 24 It is noteworthy that in our previous study of FL Sleeve outcomes in patients with Marfan syndrome, no patient developed aortic dissection during follow-up.
25
AVR including composite root replacement is associated with a higher rate of cardiac mortality and valve-related morbidity versus AVS techniques.
2 The David valve-sparing procedure has been suggested as the "gold standard" for patients with aortic root dilation, 5 but in many centers adoption of AVS procedures has remained around 15%. On the other hand, due to complexity of the David procedure, Ouzounian et al 2 recommended that patients should be referred to large centers with highly experienced surgeons. However, even in a multicenter trial of highly experienced surgeons, 7% of patients developed greater than mild (2 þ ) AI at 1 year. 26 We believe that valve-sparing procedures could be available in more centers with the simplified FL Sleeve procedure. We are encouraged that the outcomes of the FL Sleeve procedure are excellent, although further study is warranted.
Limitations
We recognize the following limitations in our study: (1) a retrospective and single-center study, (2) no comparison between outcomes of FL Sleeve procedure and previous AVS techniques, and (3) loss to follow-up of patients' echocardiography measurements.
Conclusion
The Florida Sleeve technique is a safe, effective, and durable procedure for aortic root dilation and functional aortic insufficiency. Patients' long-term survival, freedom from reoperation, and freedom from significant AI are excellent. Owing to the simplicity and reproducibility of the FL Sleeve procedure, it can be an appropriate alternative valve-sparing procedure.
Note
The study was presented at the 53th annual meeting of Society of Thoracic Surgeon (STS), January 21-25, 2017, Houston, TX, USA.
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